Please try another search
YTD | 3M | 1Y | 3Y | 5Y | 10Y | |
---|---|---|---|---|---|---|
Growth of 1000 | 1085 | 1055 | 1088 | 1180 | 1751 | 3219 |
Fund Return | 8.54% | 5.49% | 8.8% | 5.67% | 11.86% | 12.4% |
Place in category | 46 | 82 | 66 | 172 | 20 | 60 |
% in Category | 5 | 9 | 7 | 32 | 6 | 16 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Schroder Global Equity Fund I Acc | 1.65B | 7.06 | 11.71 | 13.08 | ||
Schroder Global Equity Fund I Inc | 1.65B | 7.04 | 11.70 | 13.07 | ||
Schroder Asian Income Z Acc | 1.34B | 3.93 | 2.15 | 8.61 | ||
Schroder Asian Income Z Inc | 1.34B | 3.93 | 2.16 | 8.62 | ||
Alpha Plus Fund L GBP Accumulation | 1.33B | -0.52 | -5.45 | 9.07 |
Name | Rating | Total Assets | YTD% | 3Y% | 10Y% | |
---|---|---|---|---|---|---|
Janus Global Life Sciences Fund U G | 3.96B | 7.74 | 9.50 | 13.38 | ||
Wellington Global Health Care EquiG | 2.52B | 5.25 | 5.27 | 13.12 | ||
Global Health Care Fund W Acc GBP | 116.67M | -8.92 | 12.63 | 14.43 | ||
Adamant Medtech I GBP | 1.51B | 10.64 | 6.33 | 14.31 | ||
Pharmaceuticals Index Trust F Acc | 262.41K | 8.14 | 10.01 | 11.74 |
Name | ISIN | Weight % | Last | Change % | |
---|---|---|---|---|---|
Eli Lilly | US5324571083 | 8.44 | 787.24 | +3.22% | |
Merck&Co | US58933Y1055 | 7.05 | 131.74 | +2.39% | |
Thermo Fisher Scientific | US8835561023 | 5.08 | 598.54 | +0.63% | |
Elevance Health | US0367521038 | 3.91 | 540.00 | +1.00% | |
Novo Nordisk B | DK0062498333 | 3.56 | 917.1 | +0.78% |
Type | Daily | Weekly | Monthly |
---|---|---|---|
Moving Averages | Strong Buy | Buy | Buy |
Technical Indicators | Strong Buy | Strong Buy | Strong Buy |
Summary | Strong Buy | Strong Buy | Strong Buy |
Are you sure you want to block %USER_NAME%?
By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.
%USER_NAME% was successfully added to your Block List
Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.
I feel that this comment is:
Thank You!
Your report has been sent to our moderators for review